Valuation: Bould Opportunities PLC

Market Cap 5.71K 5.09K 4.65K 4.24K 7.99K 539K 8.2K 55.88K 22.35K 286K 21.42K 20.96K 901K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -69.77K -63.81K -58.12K -110K -7.4M -112K -767K -307K -3.92M -294K -288K -12.36M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
65.12%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 14/05/2021
Chief Tech/Sci/R&D Officer 61 02/01/2025
Director TitleAgeSince
Director/Board Member 45 29/01/2019
Chairman 70 21/05/2019
Director/Board Member 61 14/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
+0.78%+5.05%+12.71%+63.67% 45.34B
+2.34%+11.70%-8.86%+37.17% 39.94B
+0.89%+3.61%-3.84%+24.93% 23.19B
+0.70%-2.96%+45.60%+34.62% 18.69B
-3.56%+4.34%+31.94%+53.11% 16.74B
-4.70%+2.27%+15.36%+41.73% 15.38B
-8.02%+1.98%-29.62%-57.83% 13.13B
-14.10%-8.30%-7.08%+11.96% 10.86B
-4.50%-1.53%-11.33%+90.79% 9.95B
Average -3.06%+9.58%+4.98%+33.35% 19.32B
Weighted average by Cap. -1.48%+7.03%+6.09%+38.30%

Financials

2019 2020
Net sales - -
Net income -832K -741K -678K -618K -1.16M -78.62M -1.2M -8.15M -3.26M -41.64M -3.12M -3.06M -131M -306K -273K -249K -227K -428K -28.92M -440K -3M -1.2M -15.31M -1.15M -1.12M -48.33M
Net Debt -378K -337K -308K -281K -529K -35.72M -543K -3.7M -1.48M -18.92M -1.42M -1.39M -59.7M -84K -74.85K -68.47K -62.35K -118K -7.94M -121K -823K -329K -4.2M -315K -309K -13.27M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-